Ras Al Khaimah. Gulf Pharmaceutical Industries PSC (Julphar), one of the largest pharmaceutical manufacturers in the Middle East and Africa, has reported its financial results for the third quarter of 2020. The company generated Dh186.9 million in sales, an increase quarter on quarter by 10 per cent, credited to the successful market re-entry in Saudi Arabia, Oman, Kuwait, and Bahrain following the lifting of the temporary export suspension into these countries earlier this year. Julphar has also announced a net loss of Dh21.8 million, a substantial improvement since 2019, which is attributed to the increase in net sales, expense reduction and gross margin improvement. (Staff Report)
© Al Nisr Publishing LLC 2020. All rights reserved.Provided by SyndiGate Media Inc.